 | • レポートコード：MRC2Q12-19219 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、医療用ソフトカプセルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 医療用ソフトカプセルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用ソフトカプセルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用ソフトカプセルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの医療用ソフトカプセルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の医療用ソフトカプセルの売上および2028年までの予測に焦点を当てています。 医療用ソフトカプセルのグローバル主要企業には、GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 医療用ソフトカプセル市場は、タイプとアプリケーションによって区分されます。世界の医療用ソフトカプセル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ゼラチンタイプ、非動物性タイプ 【アプリケーション別セグメント】 病院、診療所、医療機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 医療用ソフトカプセル製品概要 - タイプ別市場（ゼラチンタイプ、非動物性タイプ） - アプリケーション別市場（病院、診療所、医療機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の医療用ソフトカプセル販売量予測2017-2028 - 世界の医療用ソフトカプセル売上予測2017-2028 - 医療用ソフトカプセルの地域別販売量 - 医療用ソフトカプセルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別医療用ソフトカプセル販売量 - 主要メーカー別医療用ソフトカプセル売上 - 主要メーカー別医療用ソフトカプセル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ゼラチンタイプ、非動物性タイプ） - 医療用ソフトカプセルのタイプ別販売量 - 医療用ソフトカプセルのタイプ別売上 - 医療用ソフトカプセルのタイプ別価格 ・アプリケーション別市場規模（病院、診療所、医療機関、その他） - 医療用ソフトカプセルのアプリケーション別販売量 - 医療用ソフトカプセルのアプリケーション別売上 - 医療用ソフトカプセルのアプリケーション別価格 ・北米市場 - 北米の医療用ソフトカプセル市場規模（タイプ別、アプリケーション別） - 主要国別の医療用ソフトカプセル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの医療用ソフトカプセル市場規模（タイプ別、アプリケーション別） - 主要国別の医療用ソフトカプセル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の医療用ソフトカプセル市場規模（タイプ別、アプリケーション別） - 主要国別の医療用ソフトカプセル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の医療用ソフトカプセル市場規模（タイプ別、アプリケーション別） - 主要国別の医療用ソフトカプセル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの医療用ソフトカプセル市場規模（タイプ別、アプリケーション別） - 主要国別の医療用ソフトカプセル市場規模（トルコ、サウジアラビア） ・企業情報 GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Group ・産業チェーン及び販売チャネル分析 - 医療用ソフトカプセルの産業チェーン分析 - 医療用ソフトカプセルの原材料 - 医療用ソフトカプセルの生産プロセス - 医療用ソフトカプセルの販売及びマーケティング - 医療用ソフトカプセルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 医療用ソフトカプセルの産業動向 - 医療用ソフトカプセルのマーケットドライバー - 医療用ソフトカプセルの課題 - 医療用ソフトカプセルの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Medical Soft Capsules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Medical Soft Capsules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Medical Soft Capsules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Medical Soft Capsules include GSK, Aenova, Catalent, Boehringer Ingelheim, Nature’s Bounty, Patheon (Thermo Fisher Scientific), Procaps, AstraZeneca and Aland, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Medical Soft Capsules manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Medical Soft Capsules market. Further, it explains the major drivers and regional dynamics of the global Medical Soft Capsules market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GSK
Aenova
Catalent
Boehringer Ingelheim
Nature’s Bounty
Patheon (Thermo Fisher Scientific)
Procaps
AstraZeneca
Aland
Vertex
Novartis
EuroCaps
Strides Pharma Science
Captek
Soft Gel Technologies
NextPharma (from Lonza)
Roche
Amway
Sirio Pharma Co., Ltd
Weihai Baihe Biology Technological Co., Ltd
Douglas
Shineway Pharma
Tsinghua Unigroup
Donghai Pharm
Yi Chao
Yuwang Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Medical Soft Capsules Segment by Type
Gelatin Type
Non-Animal Type
Medical Soft Capsules Segment by Application
Hospital
Clinic
Medical Institutions
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Soft Capsules market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Medical Soft Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Medical Soft Capsules, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Medical Soft Capsules, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Soft Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Medical Soft Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Medical Soft Capsules sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Aenova, Catalent, Boehringer Ingelheim, Nature’s Bounty, Patheon (Thermo Fisher Scientific), Procaps, AstraZeneca and Aland, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Medical Soft Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Medical Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Soft Capsules sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Medical Soft Capsules Product Introduction
1.2 Market by Type
1.2.1 Global Medical Soft Capsules Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gelatin Type
1.2.3 Non-Animal Type
1.3 Market by Application
1.3.1 Global Medical Soft Capsules Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Medical Soft Capsules Sales Estimates and Forecasts 2017-2028
2.2 Global Medical Soft Capsules Revenue Estimates and Forecasts 2017-2028
2.3 Global Medical Soft Capsules Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Medical Soft Capsules Sales by Region
2.4.1 Global Medical Soft Capsules Sales by Region (2017-2022)
2.4.2 Global Sales Medical Soft Capsules by Region (2023-2028)
2.5 Global Medical Soft Capsules Revenue by Region
2.5.1 Global Medical Soft Capsules Revenue by Region (2017-2022)
2.5.2 Global Medical Soft Capsules Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Medical Soft Capsules Sales by Manufacturers
3.1.1 Global Top Medical Soft Capsules Manufacturers by Sales (2017-2022)
3.1.2 Global Medical Soft Capsules Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Soft Capsules in 2021
3.2 Global Medical Soft Capsules Revenue by Manufacturers
3.2.1 Global Medical Soft Capsules Revenue by Manufacturers (2017-2022)
3.2.2 Global Medical Soft Capsules Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Medical Soft Capsules Revenue in 2021
3.3 Global Medical Soft Capsules Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Medical Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Medical Soft Capsules Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Soft Capsules Sales by Type
4.1.1 Global Medical Soft Capsules Historical Sales by Type (2017-2022)
4.1.2 Global Medical Soft Capsules Forecasted Sales by Type (2023-2028)
4.1.3 Global Medical Soft Capsules Sales Market Share by Type (2017-2028)
4.2 Global Medical Soft Capsules Revenue by Type
4.2.1 Global Medical Soft Capsules Historical Revenue by Type (2017-2022)
4.2.2 Global Medical Soft Capsules Forecasted Revenue by Type (2023-2028)
4.2.3 Global Medical Soft Capsules Revenue Market Share by Type (2017-2028)
4.3 Global Medical Soft Capsules Price by Type
4.3.1 Global Medical Soft Capsules Price by Type (2017-2022)
4.3.2 Global Medical Soft Capsules Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Medical Soft Capsules Sales by Application
5.1.1 Global Medical Soft Capsules Historical Sales by Application (2017-2022)
5.1.2 Global Medical Soft Capsules Forecasted Sales by Application (2023-2028)
5.1.3 Global Medical Soft Capsules Sales Market Share by Application (2017-2028)
5.2 Global Medical Soft Capsules Revenue by Application
5.2.1 Global Medical Soft Capsules Historical Revenue by Application (2017-2022)
5.2.2 Global Medical Soft Capsules Forecasted Revenue by Application (2023-2028)
5.2.3 Global Medical Soft Capsules Revenue Market Share by Application (2017-2028)
5.3 Global Medical Soft Capsules Price by Application
5.3.1 Global Medical Soft Capsules Price by Application (2017-2022)
5.3.2 Global Medical Soft Capsules Price Forecast by Application (2023-2028)
6 North America
6.1 North America Medical Soft Capsules Market Size by Type
6.1.1 North America Medical Soft Capsules Sales by Type (2017-2028)
6.1.2 North America Medical Soft Capsules Revenue by Type (2017-2028)
6.2 North America Medical Soft Capsules Market Size by Application
6.2.1 North America Medical Soft Capsules Sales by Application (2017-2028)
6.2.2 North America Medical Soft Capsules Revenue by Application (2017-2028)
6.3 North America Medical Soft Capsules Market Size by Country
6.3.1 North America Medical Soft Capsules Sales by Country (2017-2028)
6.3.2 North America Medical Soft Capsules Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Medical Soft Capsules Market Size by Type
7.1.1 Europe Medical Soft Capsules Sales by Type (2017-2028)
7.1.2 Europe Medical Soft Capsules Revenue by Type (2017-2028)
7.2 Europe Medical Soft Capsules Market Size by Application
7.2.1 Europe Medical Soft Capsules Sales by Application (2017-2028)
7.2.2 Europe Medical Soft Capsules Revenue by Application (2017-2028)
7.3 Europe Medical Soft Capsules Market Size by Country
7.3.1 Europe Medical Soft Capsules Sales by Country (2017-2028)
7.3.2 Europe Medical Soft Capsules Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medical Soft Capsules Market Size by Type
8.1.1 Asia Pacific Medical Soft Capsules Sales by Type (2017-2028)
8.1.2 Asia Pacific Medical Soft Capsules Revenue by Type (2017-2028)
8.2 Asia Pacific Medical Soft Capsules Market Size by Application
8.2.1 Asia Pacific Medical Soft Capsules Sales by Application (2017-2028)
8.2.2 Asia Pacific Medical Soft Capsules Revenue by Application (2017-2028)
8.3 Asia Pacific Medical Soft Capsules Market Size by Region
8.3.1 Asia Pacific Medical Soft Capsules Sales by Region (2017-2028)
8.3.2 Asia Pacific Medical Soft Capsules Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Medical Soft Capsules Market Size by Type
9.1.1 Latin America Medical Soft Capsules Sales by Type (2017-2028)
9.1.2 Latin America Medical Soft Capsules Revenue by Type (2017-2028)
9.2 Latin America Medical Soft Capsules Market Size by Application
9.2.1 Latin America Medical Soft Capsules Sales by Application (2017-2028)
9.2.2 Latin America Medical Soft Capsules Revenue by Application (2017-2028)
9.3 Latin America Medical Soft Capsules Market Size by Country
9.3.1 Latin America Medical Soft Capsules Sales by Country (2017-2028)
9.3.2 Latin America Medical Soft Capsules Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Medical Soft Capsules Market Size by Type
10.1.1 Middle East and Africa Medical Soft Capsules Sales by Type (2017-2028)
10.1.2 Middle East and Africa Medical Soft Capsules Revenue by Type (2017-2028)
10.2 Middle East and Africa Medical Soft Capsules Market Size by Application
10.2.1 Middle East and Africa Medical Soft Capsules Sales by Application (2017-2028)
10.2.2 Middle East and Africa Medical Soft Capsules Revenue by Application (2017-2028)
10.3 Middle East and Africa Medical Soft Capsules Market Size by Country
10.3.1 Middle East and Africa Medical Soft Capsules Sales by Country (2017-2028)
10.3.2 Middle East and Africa Medical Soft Capsules Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Aenova
11.2.1 Aenova Corporation Information
11.2.2 Aenova Overview
11.2.3 Aenova Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aenova Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aenova Recent Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Overview
11.3.3 Catalent Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Catalent Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Catalent Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Nature’s Bounty
11.5.1 Nature’s Bounty Corporation Information
11.5.2 Nature’s Bounty Overview
11.5.3 Nature’s Bounty Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nature’s Bounty Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nature’s Bounty Recent Developments
11.6 Patheon (Thermo Fisher Scientific)
11.6.1 Patheon (Thermo Fisher Scientific) Corporation Information
11.6.2 Patheon (Thermo Fisher Scientific) Overview
11.6.3 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Patheon (Thermo Fisher Scientific) Recent Developments
11.7 Procaps
11.7.1 Procaps Corporation Information
11.7.2 Procaps Overview
11.7.3 Procaps Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Procaps Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Procaps Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Aland
11.9.1 Aland Corporation Information
11.9.2 Aland Overview
11.9.3 Aland Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aland Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aland Recent Developments
11.10 Vertex
11.10.1 Vertex Corporation Information
11.10.2 Vertex Overview
11.10.3 Vertex Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vertex Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vertex Recent Developments
11.11 Novartis
11.11.1 Novartis Corporation Information
11.11.2 Novartis Overview
11.11.3 Novartis Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Recent Developments
11.12 EuroCaps
11.12.1 EuroCaps Corporation Information
11.12.2 EuroCaps Overview
11.12.3 EuroCaps Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 EuroCaps Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuroCaps Recent Developments
11.13 Strides Pharma Science
11.13.1 Strides Pharma Science Corporation Information
11.13.2 Strides Pharma Science Overview
11.13.3 Strides Pharma Science Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Strides Pharma Science Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Strides Pharma Science Recent Developments
11.14 Captek
11.14.1 Captek Corporation Information
11.14.2 Captek Overview
11.14.3 Captek Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Captek Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Captek Recent Developments
11.15 Soft Gel Technologies
11.15.1 Soft Gel Technologies Corporation Information
11.15.2 Soft Gel Technologies Overview
11.15.3 Soft Gel Technologies Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Soft Gel Technologies Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Soft Gel Technologies Recent Developments
11.16 NextPharma (from Lonza)
11.16.1 NextPharma (from Lonza) Corporation Information
11.16.2 NextPharma (from Lonza) Overview
11.16.3 NextPharma (from Lonza) Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 NextPharma (from Lonza) Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 NextPharma (from Lonza) Recent Developments
11.17 Roche
11.17.1 Roche Corporation Information
11.17.2 Roche Overview
11.17.3 Roche Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Roche Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Roche Recent Developments
11.18 Amway
11.18.1 Amway Corporation Information
11.18.2 Amway Overview
11.18.3 Amway Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Amway Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Amway Recent Developments
11.19 Sirio Pharma Co., Ltd
11.19.1 Sirio Pharma Co., Ltd Corporation Information
11.19.2 Sirio Pharma Co., Ltd Overview
11.19.3 Sirio Pharma Co., Ltd Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Sirio Pharma Co., Ltd Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Sirio Pharma Co., Ltd Recent Developments
11.20 Weihai Baihe Biology Technological Co., Ltd
11.20.1 Weihai Baihe Biology Technological Co., Ltd Corporation Information
11.20.2 Weihai Baihe Biology Technological Co., Ltd Overview
11.20.3 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Weihai Baihe Biology Technological Co., Ltd Recent Developments
11.21 Douglas
11.21.1 Douglas Corporation Information
11.21.2 Douglas Overview
11.21.3 Douglas Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Douglas Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Douglas Recent Developments
11.22 Shineway Pharma
11.22.1 Shineway Pharma Corporation Information
11.22.2 Shineway Pharma Overview
11.22.3 Shineway Pharma Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Shineway Pharma Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Shineway Pharma Recent Developments
11.23 Tsinghua Unigroup
11.23.1 Tsinghua Unigroup Corporation Information
11.23.2 Tsinghua Unigroup Overview
11.23.3 Tsinghua Unigroup Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Tsinghua Unigroup Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Tsinghua Unigroup Recent Developments
11.24 Donghai Pharm
11.24.1 Donghai Pharm Corporation Information
11.24.2 Donghai Pharm Overview
11.24.3 Donghai Pharm Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Donghai Pharm Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Donghai Pharm Recent Developments
11.25 Yi Chao
11.25.1 Yi Chao Corporation Information
11.25.2 Yi Chao Overview
11.25.3 Yi Chao Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Yi Chao Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Yi Chao Recent Developments
11.26 Yuwang Group
11.26.1 Yuwang Group Corporation Information
11.26.2 Yuwang Group Overview
11.26.3 Yuwang Group Medical Soft Capsules Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Yuwang Group Medical Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Yuwang Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Soft Capsules Industry Chain Analysis
12.2 Medical Soft Capsules Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Soft Capsules Production Mode & Process
12.4 Medical Soft Capsules Sales and Marketing
12.4.1 Medical Soft Capsules Sales Channels
12.4.2 Medical Soft Capsules Distributors
12.5 Medical Soft Capsules Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Medical Soft Capsules Industry Trends
13.2 Medical Soft Capsules Market Drivers
13.3 Medical Soft Capsules Market Challenges
13.4 Medical Soft Capsules Market Restraints
14 Key Findings in The Global Medical Soft Capsules Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer